Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-032691)

Filing Details

Accession Number:: 0001127602-13-032691
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-22 17:22:47
Reporting Period:: 2013-11-21

Filing Date:: 2013-11-22
Accepted Time:: 2013-11-22 17:22:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235598	M James Frates	Connaught House 1 Burlington Road Dublin 4 Ireland	Svp & Cfo, Alkermes Plc	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2013-11-21	4,988	$37.89	95,514	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	4,000	Indirect	By Sons

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.86 to $37.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.